NARSAD
Welcome, guest
[login or register]
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Helen S. Mayberg, M.D. (Distinguished Investigator 2002) of Rotman Research Institute, will pilot the use of Deep Brain Stimulation (DBS), a reversible method of selective brain lesioning, as an alternative to standard functional neurosurgical approaches for treating severe refractory major depression.  The study should provide not only pilot data on a potentially effective and safe treatment option for severely ill patients, but new insights into neural circuitry mediating normal and abnormal mood states.  Literature demonstrates strong evidence that DBS' use to treat Parkinson's disease and other movement disorders is comparable to direct lesioning of the brain, but with reversible physiological and clinical effects.  The target stimulation site for this study will be the subcaudate tract, bilaterally.  The subcaudate tract region and its cortical projections overlap areas showing common response-specific metabolic decreases in her imaging studies of pharmacological and non-pharmacological treatment of major depression.  Similar changes following successful treatment with ECT and subcaudate tractotomy have also been reported.  Across studies, clinical response appears to best correlate with limbic/paralimbic decreases involving the orbital frontal cortex and subgenual cingulate regions.  Based on these findings, Dr. Mayberg hypothesizes that this combination of limbic-paralimbic decreases and dorsal cortical increases are necessary for clinical remission.  The use of the reversible DBS approach combined with longitudinal functional brain imaging provides an opportunity to refine an important clinical treatment option and to test hypotheses regarding which functional pathway changes are necessary for clinical remission.  This combined approach has been extremely productive in refining surgical approaches for refractory Parkinson's disease and in developing DBS as a mainstream treatment for this disorder-now replacing radiofrequency lesioning. 

Program Area: MOOD DISORDERS\Depression (Unipolar)

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award Application Deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Awards Earliest Start Date: September 15, 2008

2009 Independent Investigator Award Application Deadline: March 5, 2009

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009
NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us